OpenAI acquires Orchestra Bio to expand AI in drug development
OpenAI has acquired Orchestra Bio, a startup building AI agents that help pharmaceutical teams manage drug development, and will integrate its team and technology into Rosalind, OpenAI's life sciences model and related Workbench tool.
Read the full story at OpenAI News ↗
Timeline · 8 reports
- 2026-10-20 23:40 · SiliconANGLE AI
OpenAI acquires Orchestra Bio to bring AI agents into drug development - 2026-10-20 20:53 · Unite.AI
OpenAI Acquires Orchestra Bio to Expand Rosalind Life Sciences Tools - 2026-10-20 20:35 · TechCrunch AI
OpenAI acquires startup Orchestra Bio to beef up its biotech business - 2026-10-20 18:24 · r/ArtificialInteligence
OpenAI acquires Orchestra Bio to connect research AI with drug-development operations - 2026-10-20 18:24 · r/OpenAI
OpenAI acquires Orchestra Bio to connect research AI with drug-development operations - 2026-10-20 18:10 · AlphaSignal
OpenAI Buys Orchestra Bio to Push Rosalind Into Drug Development Operations - 2026-10-20 17:55 · Axios AI+
Exclusive: OpenAI has acquired Orchestra Bio - 2026-10-20 00:00 · OpenAI News
OpenAI acquires Orchestra Bio